Home > Insider Trading > Filing (0001127602-18-011407)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711404	Cooper Companies Inc	COO	Ophthalmic Goods (3851)	942657368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1181958	R Carol Kaufman	6140 Stoneridge Mall Drive Suite 590 Pleasanton CA 94588	Evp, Sec. & Chief Gov. Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-03-12	13,362	$95.74	59,305	No	4	M	Direct
Common Stock	Disposition	2018-03-12	1,782	$241.09	57,523	No	4	S	Direct
Common Stock	Disposition	2018-03-12	2,480	$242.30	55,043	No	4	S	Direct
Common Stock	Disposition	2018-03-12	2,342	$243.21	52,701	No	4	S	Direct
Common Stock	Disposition	2018-03-12	1,771	$244.23	50,930	No	4	S	Direct
Common Stock	Disposition	2018-03-12	3,700	$245.58	47,230	No	4	S	Direct
Common Stock	Disposition	2018-03-12	1,087	$246.52	46,143	No	4	S	Direct
Common Stock	Disposition	2018-03-12	200	$247.31	45,943	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-03-12	13,362	$0.00	13,362	$95.74

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2022-12-11	No	4	M	Direct

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.67 to $241.635. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
The sales price represents a weighted average of sales prices ranging between $241.70 and $242.68.
The sales price represents a weighted average of sales prices ranging between $242.72 and $243.71.
The sales price represents a weighted average of sales prices ranging between $243.73 and $244.70.
The sales price represents a weighted average of sales prices ranging between $245.10 $246.095.
The sales price represents a weighted average of sales prices ranging between $246.14 and $246.97.
The sales price represents a weighted average of sales prices ranging between $247.30 and $247.37.
12/12/12 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/12/13; 1/5 shall vest on 12/12/14; 1/5 shall vest on 12/12/15; 1/5 shall vest on 12/12/16; and 1/5 shall vest on 12/12/17.